Evaluating risk: benefit ratio of fat-soluble vitamin supplementation to sars-cov-2-infected autoimmune and cancer patients: do vitamin-drug interactions exist?

HIGHLIGHTS

  • who: Radwa Y. Mekky et al. from the Department of Pharmacology and Toxicology, Faculty of Pharmacy, October University for Modern Sciences Antonius Deusinglaan, AV Groningen, The Netherlands have published the Article: Evaluating Risk: Benefit Ratio of Fat-Soluble Vitamin Supplementation to SARS-CoV-2-Infected Autoimmune and Cancer Patients: Do Vitamin-Drug Interactions Exist?, in the Journal: Life 2022, 1654 of /2022/
  • what: Relevant publications with detailed information were included includingresearch articles, review articles and book chapters were evaluated and summarized to fulfill the purpose of this review article.
  • future: Tumors Status of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?